Pharmaceutical industry doing more to improve access to medicine in...
The world's leading pharmaceutical companies are doing more to improve access to medicine in developing countries, with a raft of new initiatives, scale-ups and innovations over the last two years....
View ArticleStudy of generic antiepilepsy drugs finds minimal differences
A comparison of two of the most disparate approved generic antiepileptic drugs found minimal differences when compared under rigorous testing procedures in people with epilepsy, according to research...
View ArticleFDA: Ziprasidone can cause rare, serious adverse drug reaction
(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food...
View ArticleWorldwide treatment of hepatitis C could be within sight at the right cost
Lowering the cost of hepatitis C drugs is possible and key to achieving global access to treatment, according to new research by the University of Liverpool and Imperial College London.
View ArticleFirst generic Abilify approved
(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.
View ArticleEU suspends sale of 700 generic drugs made in India
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed on Monday.
View ArticleACP: Doctors should prescribe generic medications whenever possible
All clinicians should prescribe generic medications whenever possible as a way to improve adherence to therapy and clinical outcomes while containing costs, the American College of Physicians (ACP)...
View ArticleFDA OKs first generic for Gleevec leukemia pill
U.S. regulators have approved the first generic version of one of the first very effective—and expensive—cancer drugs, Gleevec, which costs about $10,000 a month.
View ArticleFTC accuses Endo, other drugmakers of antitrust violations
The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain...
View ArticleA legal approach to reducing drug spending
In a new analysis published in the May issue of Health Affairs, Aaron Kesselheim, MD, JD, MPH, associate professor of medicine and director of the Program on Regulation, Therapeutics, and Law in the...
View ArticleFDA approves first generic version of tamiflu
(HealthDay)—The first generic version of the flu medication Tamiflu has been approved by the U.S. Food and Drug Administration.
View ArticleOral drug delivery company says opioid lawsuit has no merit
One of the companies alleged to have conspired to keep generic versions of a popular opioid treatment off the market says the antitrust lawsuit has no merit.
View ArticleAfter harsh light, a cheaper version of EpiPen from Mylan
Mylan is releasing a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew scorn from parents nationwide and spawned Congressional...
View ArticleCVS generic competitor to EpiPen, sold at a 6th the price
CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of...
View ArticleAfrica gets generic version of most effective HIV drug
The generic version of the most advanced drug against HIV has been introduced in Kenya, a first in Africa where more than 25 million have the disease, the NGO Unitaid said Wednesday.
View ArticleHow Big Pharma is hindering treatment of the opioid addiction epidemic
"A crippling problem.""A total epidemic.""A problem like nobody understands." These are the words President Trump used to describe the opioid epidemic ravaging the country during a White House...
View ArticleSavings less than expected for generic oral chemotherapy
A study by researchers at the University of North Carolina Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost savings for a generic version of an orally...
View ArticleAdverse events spike after blood pressure meds go generic in Canada
One month after generic versions of three widely-used blood pressure drugs became available in Canada, hospital visits for adverse events spiked in generic drug users, according to new research in...
View ArticleGood news, guys: Viagra prices start to tumble today
(HealthDay)—In news that will delight men who've had difficulties in the bedroom, two generic versions of the erectile dysfunction drug Viagra are scheduled to hit the market Monday.
View Article